跳到正文
Swissmedic 药品质量与 GMP 更新·· 22 天前AI 评分55

Swissmedic 更新人用药品新上市许可及变更与扩展 HAM 表格,新版自2026年11月1日起生效

Update to the forms New authorisation of human medicinal products and Variations and extensions HAM

AI 导读

Swissmedic 更新了人用药品新上市许可及变更与扩展(HAM)表格中的药品类别选项,修订版表格自2026年11月1日起生效。自2026年11月1日起提交的相关申请,申请人须按更新后的类别列表在表格第1或第2页的下拉菜单中选择。

正文 · 原文

Update to the forms New authorisation of human medicinal products and Variations and extensions HAM

Due to changes to the medicinal products categories and the central publication of officially mandated information material by conformation, an update to the forms New authorisation of human medicinal products and Variations and extensions HAM is necessary

01.11.2026

Swissmedic has updated the choice of medicinal product categories. The changes take into account the current state of scientific and technical knowledge and contribute to up-to-date classification of medicinal products.

Applicants are therefore requested to select the medicinal product category according to the updated list in the drop down menu on page 1 or 2 of the forms mentioned for relevant applications submitted from 1 November 2026.

In addition, new framework conditions for the central electronic publication of officially mandated information materials have been in force since 1 August 2026 (see Changes to the guidance document RMP ICH E2E information submission HMP).

Medicinal products with a known active substance (KAS) with or without innovation and biosimilars publish the officially mandated information material by conformation and with reference to the relevant reference medicinal product/reference product. More detailed information on this is to be provided by the applicant in sections 6.10 KAS with/without innovation and biosimilars and/or 5.10 New pharmaceutical form of the forms mentioned.

The revised forms are valid with effect from 1 November 2026.

来源:Swissmedic 药品质量与 GMP 更新 · swissmedic.ch